A partial differential equation model of metastasized prostatic cancer

Area of Science:

• Mathematical Biology
• Oncology
• Computational Science

Background:

• Metastatic prostate cancer treatment relies on androgen ablation, but castration-resistant cells emerge, leading to therapy failure.
• Prostate cancer commonly metastasizes to bone, posing significant therapeutic challenges.
• Understanding the dynamics of tumor growth and treatment response is crucial for developing effective strategies.

Purpose of the Study:

• To develop a mathematical model simulating prostate cancer metastasis to bone and its response to androgen ablation therapy.
• To analyze the existence and uniqueness of solutions for the free boundary problem governing tumor growth.
• To evaluate the therapeutic potential of various treatment strategies through numerical simulations.

Main Methods:

• Development of a partial differential equation model for prostate cancer growth and treatment response.
• Mathematical derivation of existence and uniqueness results for the free boundary problem, including the radially symmetric case.
• Numerical simulations of 2D radially symmetric tumors to assess treatment efficacy.

Main Results:

• The mathematical model provides existence and uniqueness of solutions for the tumor growth dynamics.
• Numerical simulations successfully replicate observed clinical responses to prostate cancer treatments.
• The study identifies potential treatment strategies that could lead to tumor remission.

Conclusions:

• The developed partial differential equation model offers a robust framework for studying prostate cancer bone metastasis.
• The model's ability to simulate clinical responses highlights its potential for predicting treatment outcomes.
• This research underscores the value of mathematical modeling in advancing prostate cancer therapeutics and overcoming treatment resistance.